1. Web alert

   News 06 January 2014 Pages: 397 - 398

2. Web alert

   News Pages: 397 - 398

3. Literature alert

   Abstract Pages: 399 - 401

4. Literature alert

   Abstract 06 January 2014 Pages: 399 - 401

5. Recombinant bactericidal/permeability-increasing protein reduced morbidity in children with severe meningococcal sepsis

   • Neal H. Steigbigel

   Clinical Trials Report Pages: 405 - 406

6. Recombinant bactericidal/permeability-increasing protein reduced morbidity in children with severe meningococcal sepsis

   • Neal H. Steigbigel

   Clinical Trials Report 06 January 2014 Pages: 405 - 406

7. Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis

   • Ofer Levy
   • Peter Elsbach

   OriginalPaper 06 January 2014 Pages: 407 - 412

8. Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis

   • Ofer Levy
   • Peter Elsbach

   OriginalPaper Pages: 407 - 412

9. The role of protein C in sepsis

   • Mark R. Looney
   • Michael A. Matthay

   OriginalPaper 06 January 2014 Pages: 413 - 418

10. The role of protein C in sepsis

    • Mark R. Looney
    • Michael A. Matthay

    OriginalPaper Pages: 413 - 418

11. Genetic analysis of host responses in sepsis

    • Bruce Beutler
    • Richard J. Ulevitch

    OriginalPaper Pages: 419 - 426

12. Genetic analysis of host responses in sepsis

    • Bruce Beutler
    • Richard J. Ulevitch

    OriginalPaper 06 January 2014 Pages: 419 - 426

13. Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome

    • Julian Knight

    OriginalPaper 06 January 2014 Pages: 427 - 439

14. Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome

    • Julian Knight

    OriginalPaper Pages: 427 - 439

15. The increasing role of Acinetobacter species as nosocomial pathogens

    • Eugénie Bergogne-Bérézin

    OriginalPaper 06 January 2014 Pages: 440 - 444

16. The increasing role of Acinetobacter species as nosocomial pathogens

    • Eugénie Bergogne-Bérézin

    OriginalPaper Pages: 440 - 444

17. Recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection

    • Barry J. Hartman

    Clinical Trials Report 06 January 2014 Pages: 447 - 448

18. Recombinant granulocyte colony-stimulating factor as adjunctive therapy for limb-threatening diabetic foot infection

    • Barry J. Hartman

    Clinical Trials Report Pages: 447 - 448

19. Linezolid versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

    • Barry J. Hartman

    Clinical Trials Report Pages: 448 - 449

20. Linezolid versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections

    • Barry J. Hartman

    Clinical Trials Report 06 January 2014 Pages: 448 - 449

21. Fungal infections of the bones and joints

    • Melissa D. Johnson
    • John R. Perfect

    OriginalPaper 06 January 2014 Pages: 450 - 460

22. Fungal infections of the bones and joints

    • Melissa D. Johnson
    • John R. Perfect

    OriginalPaper Pages: 450 - 460

23. Recent considerations in recurrent cellulitis

    • Larry M. Baddour

    OriginalPaper Pages: 461 - 465

24. Recent considerations in recurrent cellulitis

    • Larry M. Baddour

    OriginalPaper 06 January 2014 Pages: 461 - 465

25. Hepatitis C virus infection in HIV-infected patients

    • Mark S. Sulkowski

    OriginalPaper Pages: 469 - 476

26. Hepatitis C virus infection in HIV-infected patients

    • Mark S. Sulkowski

    OriginalPaper 06 January 2014 Pages: 469 - 476